[Federal Register Volume 86, Number 26 (Wednesday, February 10, 2021)]
[Notices]
[Page 8929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02688]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on March 16, 2021. A sample of agenda items to be discussed
during the public session includes: An overview of fiscal year 2020
medical related events; a discussion on the status of the NRC's patient
release evaluation of emerging brachytherapy sources; a discussion on
calibration procedures for existing and emerging brachytherapy sources;
a discussion on the current ACMUI reporting structure; and an overview
on the consequences of radiopharmaceutical extravasation and
therapeutic interventions in nuclear medicine. The agenda is subject to
change. The current agenda and any updates will be available on the
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Ms.
Kellee Jamerson at the contact information below.
DATES: Date and Time for Open Session: Tuesday, March 16, 2021, from
10:00 a.m. to 3:45 p.m. EST.
ADDRESSES:
------------------------------------------------------------------------
Date Webinar information
------------------------------------------------------------------------
March 16, 2021............................ Link: https://usnrc.webex.com.
Event number: 199 910 9533.
------------------------------------------------------------------------
Public Participation: Due to the ongoing COVID-19 public health
emergency, the meeting will be held as a webinar using Cisco WebEx. Any
member of the public who wishes to participate in any portion of this
meeting should register in advance of the meeting by accessing the
provided link above. Upon successful registration, a confirmation email
will be generated providing the telephone bridge line and a link to
join the webinar on the day of the meeting. Members of the public
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any
questions regarding the meeting, persons should contact Ms. Jamerson
using the information below.
FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email:
[email protected], telephone: 301-415-7408.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson using the contact information listed
above. All submittals must be received by the close of business on
March 10, 2021 and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about May 3, 2021.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 4th day of February, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-02688 Filed 2-9-21; 8:45 am]
BILLING CODE 7590-01-P